Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of exenatide once weekly (QW) and insulin
detemir with respect to glycemic control, body weight, lipids, safety, tolerability, and
patient reported outcomes.